【市場調査レポート】エノキサパリンナトリウムAPIのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Enoxaparin Sodium API Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。エノキサパリンナトリウムAPIのグローバル市場インサイト・予測（～2028年） / Global Enoxaparin Sodium API Market Insights, Forecast to 2028 / QY2207C0274資料のイメージです。

• レポートコード：QY2207C0274
• 出版社/出版日：QYResearch / 2022年7月15日
• レポート形態：英文、PDF、110ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のエノキサパリンナトリウムAPIの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にエノキサパリンナトリウムAPIの世界市場のxxx％を占める「純度≥99％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「注射液」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のエノキサパリンナトリウムAPIの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのエノキサパリンナトリウムAPI市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのエノキサパリンナトリウムAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

エノキサパリンナトリウムAPIのグローバル主要メーカーには、Techdow、Qingdao Kangyuan Pharmaceutical、CSBIO、Dongcheng Pharmaceutical、Hepalink Pharmaceutical Group、Cisen Pharmaceutical、Qianhong Biopharma、Nanjing King-friend、Haike Group、Yino Pharma、Tianjin Chasesun Pharmaceutical、Erye Pharmaceutical、Ronnsi Pharma、Amphastar Pharmaceuticals、Suanfarma、SAJJALA BIO LABSなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

エノキサパリンナトリウムAPI市場は、種類と用途によって区分されます。世界のエノキサパリンナトリウムAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度≥99％、純度≥99.5％

【用途別セグメント】
注射液、試薬、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- エノキサパリンナトリウムAPI製品概要
- 種類別市場（純度≥99％、純度≥99.5％）
- 用途別市場（注射液、試薬、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のエノキサパリンナトリウムAPI販売量予測2017-2028
- 世界のエノキサパリンナトリウムAPI売上予測2017-2028
- エノキサパリンナトリウムAPIの地域別販売量
- エノキサパリンナトリウムAPIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別エノキサパリンナトリウムAPI販売量
- 主要メーカー別エノキサパリンナトリウムAPI売上
- 主要メーカー別エノキサパリンナトリウムAPI価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度≥99％、純度≥99.5％）
- エノキサパリンナトリウムAPIの種類別販売量
- エノキサパリンナトリウムAPIの種類別売上
- エノキサパリンナトリウムAPIの種類別価格
・用途別市場規模（注射液、試薬、その他）
- エノキサパリンナトリウムAPIの用途別販売量
- エノキサパリンナトリウムAPIの用途別売上
- エノキサパリンナトリウムAPIの用途別価格
・北米市場
- 北米のエノキサパリンナトリウムAPI市場規模（種類別、用途別）
- 主要国別のエノキサパリンナトリウムAPI市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのエノキサパリンナトリウムAPI市場規模（種類別、用途別）
- 主要国別のエノキサパリンナトリウムAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のエノキサパリンナトリウムAPI市場規模（種類別、用途別）
- 主要国別のエノキサパリンナトリウムAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のエノキサパリンナトリウムAPI市場規模（種類別、用途別）
- 主要国別のエノキサパリンナトリウムAPI市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのエノキサパリンナトリウムAPI市場規模（種類別、用途別）
- 主要国別のエノキサパリンナトリウムAPI市場規模（トルコ、サウジアラビア）
・企業情報
Techdow、Qingdao Kangyuan Pharmaceutical、CSBIO、Dongcheng Pharmaceutical、Hepalink Pharmaceutical Group、Cisen Pharmaceutical、Qianhong Biopharma、Nanjing King-friend、Haike Group、Yino Pharma、Tianjin Chasesun Pharmaceutical、Erye Pharmaceutical、Ronnsi Pharma、Amphastar Pharmaceuticals、Suanfarma、SAJJALA BIO LABS
・産業チェーン及び販売チャネル分析
- エノキサパリンナトリウムAPIの産業チェーン分析
- エノキサパリンナトリウムAPIの原材料
- エノキサパリンナトリウムAPIの生産プロセス
- エノキサパリンナトリウムAPIの販売及びマーケティング
- エノキサパリンナトリウムAPIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- エノキサパリンナトリウムAPIの産業動向
- エノキサパリンナトリウムAPIのマーケットドライバー
- エノキサパリンナトリウムAPIの課題
- エノキサパリンナトリウムAPIの阻害要因
・主な調査結果

Market Analysis and Insights: Global Enoxaparin Sodium API Market
Due to the COVID-19 pandemic, the global Enoxaparin Sodium API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for % of the Enoxaparin Sodium API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Injection Solution segment is altered to an % CAGR throughout this forecast period.
China Enoxaparin Sodium API market size is valued at US$ million in 2021, while the US and Europe Enoxaparin Sodium API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Enoxaparin Sodium API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Enoxaparin Sodium API include Techdow, Qingdao Kangyuan Pharmaceutical, CSBIO, Dongcheng Pharmaceutical, Hepalink Pharmaceutical Group, Cisen Pharmaceutical, Qianhong Biopharma, Nanjing King-friend and Haike Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Enoxaparin Sodium API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Enoxaparin Sodium API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Enoxaparin Sodium API Scope and Segment
Enoxaparin Sodium API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Enoxaparin Sodium API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99%
Purity ≥99.5%
Segment by Application
Injection Solution
Reagent
Other
By Company
Techdow
Qingdao Kangyuan Pharmaceutical
CSBIO
Dongcheng Pharmaceutical
Hepalink Pharmaceutical Group
Cisen Pharmaceutical
Qianhong Biopharma
Nanjing King-friend
Haike Group
Yino Pharma
Tianjin Chasesun Pharmaceutical
Erye Pharmaceutical
Ronnsi Pharma
Amphastar Pharmaceuticals
Suanfarma
SAJJALA BIO LABS
Production by Region
North America
Europe
China
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Enoxaparin Sodium API Product Introduction
1.2 Market by Type
1.2.1 Global Enoxaparin Sodium API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Market by Application
1.3.1 Global Enoxaparin Sodium API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Injection Solution
1.3.3 Reagent
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Enoxaparin Sodium API Production
2.1 Global Enoxaparin Sodium API Production Capacity (2017-2028)
2.2 Global Enoxaparin Sodium API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Enoxaparin Sodium API Production by Region
2.3.1 Global Enoxaparin Sodium API Historic Production by Region (2017-2022)
2.3.2 Global Enoxaparin Sodium API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
3 Global Enoxaparin Sodium API Sales in Volume & Value Estimates and Forecasts
3.1 Global Enoxaparin Sodium API Sales Estimates and Forecasts 2017-2028
3.2 Global Enoxaparin Sodium API Revenue Estimates and Forecasts 2017-2028
3.3 Global Enoxaparin Sodium API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Enoxaparin Sodium API Sales by Region
3.4.1 Global Enoxaparin Sodium API Sales by Region (2017-2022)
3.4.2 Global Sales Enoxaparin Sodium API by Region (2023-2028)
3.5 Global Enoxaparin Sodium API Revenue by Region
3.5.1 Global Enoxaparin Sodium API Revenue by Region (2017-2022)
3.5.2 Global Enoxaparin Sodium API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Enoxaparin Sodium API Production Capacity by Manufacturers
4.2 Global Enoxaparin Sodium API Sales by Manufacturers
4.2.1 Global Enoxaparin Sodium API Sales by Manufacturers (2017-2022)
4.2.2 Global Enoxaparin Sodium API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Enoxaparin Sodium API in 2021
4.3 Global Enoxaparin Sodium API Revenue by Manufacturers
4.3.1 Global Enoxaparin Sodium API Revenue by Manufacturers (2017-2022)
4.3.2 Global Enoxaparin Sodium API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Enoxaparin Sodium API Revenue in 2021
4.4 Global Enoxaparin Sodium API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Enoxaparin Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Enoxaparin Sodium API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Enoxaparin Sodium API Sales by Type
5.1.1 Global Enoxaparin Sodium API Historical Sales by Type (2017-2022)
5.1.2 Global Enoxaparin Sodium API Forecasted Sales by Type (2023-2028)
5.1.3 Global Enoxaparin Sodium API Sales Market Share by Type (2017-2028)
5.2 Global Enoxaparin Sodium API Revenue by Type
5.2.1 Global Enoxaparin Sodium API Historical Revenue by Type (2017-2022)
5.2.2 Global Enoxaparin Sodium API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Enoxaparin Sodium API Revenue Market Share by Type (2017-2028)
5.3 Global Enoxaparin Sodium API Price by Type
5.3.1 Global Enoxaparin Sodium API Price by Type (2017-2022)
5.3.2 Global Enoxaparin Sodium API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Enoxaparin Sodium API Sales by Application
6.1.1 Global Enoxaparin Sodium API Historical Sales by Application (2017-2022)
6.1.2 Global Enoxaparin Sodium API Forecasted Sales by Application (2023-2028)
6.1.3 Global Enoxaparin Sodium API Sales Market Share by Application (2017-2028)
6.2 Global Enoxaparin Sodium API Revenue by Application
6.2.1 Global Enoxaparin Sodium API Historical Revenue by Application (2017-2022)
6.2.2 Global Enoxaparin Sodium API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Enoxaparin Sodium API Revenue Market Share by Application (2017-2028)
6.3 Global Enoxaparin Sodium API Price by Application
6.3.1 Global Enoxaparin Sodium API Price by Application (2017-2022)
6.3.2 Global Enoxaparin Sodium API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Enoxaparin Sodium API Market Size by Type
7.1.1 North America Enoxaparin Sodium API Sales by Type (2017-2028)
7.1.2 North America Enoxaparin Sodium API Revenue by Type (2017-2028)
7.2 North America Enoxaparin Sodium API Market Size by Application
7.2.1 North America Enoxaparin Sodium API Sales by Application (2017-2028)
7.2.2 North America Enoxaparin Sodium API Revenue by Application (2017-2028)
7.3 North America Enoxaparin Sodium API Sales by Country
7.3.1 North America Enoxaparin Sodium API Sales by Country (2017-2028)
7.3.2 North America Enoxaparin Sodium API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Enoxaparin Sodium API Market Size by Type
8.1.1 Europe Enoxaparin Sodium API Sales by Type (2017-2028)
8.1.2 Europe Enoxaparin Sodium API Revenue by Type (2017-2028)
8.2 Europe Enoxaparin Sodium API Market Size by Application
8.2.1 Europe Enoxaparin Sodium API Sales by Application (2017-2028)
8.2.2 Europe Enoxaparin Sodium API Revenue by Application (2017-2028)
8.3 Europe Enoxaparin Sodium API Sales by Country
8.3.1 Europe Enoxaparin Sodium API Sales by Country (2017-2028)
8.3.2 Europe Enoxaparin Sodium API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Enoxaparin Sodium API Market Size by Type
9.1.1 Asia Pacific Enoxaparin Sodium API Sales by Type (2017-2028)
9.1.2 Asia Pacific Enoxaparin Sodium API Revenue by Type (2017-2028)
9.2 Asia Pacific Enoxaparin Sodium API Market Size by Application
9.2.1 Asia Pacific Enoxaparin Sodium API Sales by Application (2017-2028)
9.2.2 Asia Pacific Enoxaparin Sodium API Revenue by Application (2017-2028)
9.3 Asia Pacific Enoxaparin Sodium API Sales by Region
9.3.1 Asia Pacific Enoxaparin Sodium API Sales by Region (2017-2028)
9.3.2 Asia Pacific Enoxaparin Sodium API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Enoxaparin Sodium API Market Size by Type
10.1.1 Latin America Enoxaparin Sodium API Sales by Type (2017-2028)
10.1.2 Latin America Enoxaparin Sodium API Revenue by Type (2017-2028)
10.2 Latin America Enoxaparin Sodium API Market Size by Application
10.2.1 Latin America Enoxaparin Sodium API Sales by Application (2017-2028)
10.2.2 Latin America Enoxaparin Sodium API Revenue by Application (2017-2028)
10.3 Latin America Enoxaparin Sodium API Sales by Country
10.3.1 Latin America Enoxaparin Sodium API Sales by Country (2017-2028)
10.3.2 Latin America Enoxaparin Sodium API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Enoxaparin Sodium API Market Size by Type
11.1.1 Middle East and Africa Enoxaparin Sodium API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Enoxaparin Sodium API Revenue by Type (2017-2028)
11.2 Middle East and Africa Enoxaparin Sodium API Market Size by Application
11.2.1 Middle East and Africa Enoxaparin Sodium API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Enoxaparin Sodium API Revenue by Application (2017-2028)
11.3 Middle East and Africa Enoxaparin Sodium API Sales by Country
11.3.1 Middle East and Africa Enoxaparin Sodium API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Enoxaparin Sodium API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Techdow
12.1.1 Techdow Corporation Information
12.1.2 Techdow Overview
12.1.3 Techdow Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Techdow Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Techdow Recent Developments
12.2 Qingdao Kangyuan Pharmaceutical
12.2.1 Qingdao Kangyuan Pharmaceutical Corporation Information
12.2.2 Qingdao Kangyuan Pharmaceutical Overview
12.2.3 Qingdao Kangyuan Pharmaceutical Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Qingdao Kangyuan Pharmaceutical Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Qingdao Kangyuan Pharmaceutical Recent Developments
12.3 CSBIO
12.3.1 CSBIO Corporation Information
12.3.2 CSBIO Overview
12.3.3 CSBIO Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 CSBIO Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 CSBIO Recent Developments
12.4 Dongcheng Pharmaceutical
12.4.1 Dongcheng Pharmaceutical Corporation Information
12.4.2 Dongcheng Pharmaceutical Overview
12.4.3 Dongcheng Pharmaceutical Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Dongcheng Pharmaceutical Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Dongcheng Pharmaceutical Recent Developments
12.5 Hepalink Pharmaceutical Group
12.5.1 Hepalink Pharmaceutical Group Corporation Information
12.5.2 Hepalink Pharmaceutical Group Overview
12.5.3 Hepalink Pharmaceutical Group Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Hepalink Pharmaceutical Group Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Hepalink Pharmaceutical Group Recent Developments
12.6 Cisen Pharmaceutical
12.6.1 Cisen Pharmaceutical Corporation Information
12.6.2 Cisen Pharmaceutical Overview
12.6.3 Cisen Pharmaceutical Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Cisen Pharmaceutical Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Cisen Pharmaceutical Recent Developments
12.7 Qianhong Biopharma
12.7.1 Qianhong Biopharma Corporation Information
12.7.2 Qianhong Biopharma Overview
12.7.3 Qianhong Biopharma Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Qianhong Biopharma Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Qianhong Biopharma Recent Developments
12.8 Nanjing King-friend
12.8.1 Nanjing King-friend Corporation Information
12.8.2 Nanjing King-friend Overview
12.8.3 Nanjing King-friend Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Nanjing King-friend Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Nanjing King-friend Recent Developments
12.9 Haike Group
12.9.1 Haike Group Corporation Information
12.9.2 Haike Group Overview
12.9.3 Haike Group Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Haike Group Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Haike Group Recent Developments
12.10 Yino Pharma
12.10.1 Yino Pharma Corporation Information
12.10.2 Yino Pharma Overview
12.10.3 Yino Pharma Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Yino Pharma Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Yino Pharma Recent Developments
12.11 Tianjin Chasesun Pharmaceutical
12.11.1 Tianjin Chasesun Pharmaceutical Corporation Information
12.11.2 Tianjin Chasesun Pharmaceutical Overview
12.11.3 Tianjin Chasesun Pharmaceutical Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Tianjin Chasesun Pharmaceutical Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Tianjin Chasesun Pharmaceutical Recent Developments
12.12 Erye Pharmaceutical
12.12.1 Erye Pharmaceutical Corporation Information
12.12.2 Erye Pharmaceutical Overview
12.12.3 Erye Pharmaceutical Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Erye Pharmaceutical Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Erye Pharmaceutical Recent Developments
12.13 Ronnsi Pharma
12.13.1 Ronnsi Pharma Corporation Information
12.13.2 Ronnsi Pharma Overview
12.13.3 Ronnsi Pharma Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Ronnsi Pharma Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Ronnsi Pharma Recent Developments
12.14 Amphastar Pharmaceuticals
12.14.1 Amphastar Pharmaceuticals Corporation Information
12.14.2 Amphastar Pharmaceuticals Overview
12.14.3 Amphastar Pharmaceuticals Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Amphastar Pharmaceuticals Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Amphastar Pharmaceuticals Recent Developments
12.15 Suanfarma
12.15.1 Suanfarma Corporation Information
12.15.2 Suanfarma Overview
12.15.3 Suanfarma Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Suanfarma Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Suanfarma Recent Developments
12.16 SAJJALA BIO LABS
12.16.1 SAJJALA BIO LABS Corporation Information
12.16.2 SAJJALA BIO LABS Overview
12.16.3 SAJJALA BIO LABS Enoxaparin Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 SAJJALA BIO LABS Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 SAJJALA BIO LABS Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Enoxaparin Sodium API Industry Chain Analysis
13.2 Enoxaparin Sodium API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Enoxaparin Sodium API Production Mode & Process
13.4 Enoxaparin Sodium API Sales and Marketing
13.4.1 Enoxaparin Sodium API Sales Channels
13.4.2 Enoxaparin Sodium API Distributors
13.5 Enoxaparin Sodium API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Enoxaparin Sodium API Industry Trends
14.2 Enoxaparin Sodium API Market Drivers
14.3 Enoxaparin Sodium API Market Challenges
14.4 Enoxaparin Sodium API Market Restraints
15 Key Finding in The Global Enoxaparin Sodium API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Enoxaparin Sodium API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity ≥99%
Table 3. Major Manufacturers of Purity ≥99.5%
Table 4. Global Enoxaparin Sodium API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Enoxaparin Sodium API Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Enoxaparin Sodium API Production by Region (2017-2022) & (Tons)
Table 7. Global Enoxaparin Sodium API Production Market Share by Region (2017-2022)
Table 8. Global Enoxaparin Sodium API Production by Region (2023-2028) & (Tons)
Table 9. Global Enoxaparin Sodium API Production Market Share by Region (2023-2028)
Table 10. Global Enoxaparin Sodium API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Enoxaparin Sodium API Sales by Region (2017-2022) & (Tons)
Table 12. Global Enoxaparin Sodium API Sales Market Share by Region (2017-2022)
Table 13. Global Enoxaparin Sodium API Sales by Region (2023-2028) & (Tons)
Table 14. Global Enoxaparin Sodium API Sales Market Share by Region (2023-2028)
Table 15. Global Enoxaparin Sodium API Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Enoxaparin Sodium API Revenue Market Share by Region (2017-2022)
Table 17. Global Enoxaparin Sodium API Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Enoxaparin Sodium API Revenue Market Share by Region (2023-2028)
Table 19. Global Enoxaparin Sodium API Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Enoxaparin Sodium API Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Enoxaparin Sodium API Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Enoxaparin Sodium API Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Enoxaparin Sodium API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Enoxaparin Sodium API Revenue Share by Manufacturers (2017-2022)
Table 25. Enoxaparin Sodium API Price by Manufacturers 2017-2022 (US$/Kg)
Table 26. Global Enoxaparin Sodium API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Enoxaparin Sodium API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enoxaparin Sodium API as of 2021)
Table 28. Enoxaparin Sodium API Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Enoxaparin Sodium API Product Offered
Table 30. Date of Manufacturers Enter into Enoxaparin Sodium API Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Enoxaparin Sodium API Sales by Type (2017-2022) & (Tons)
Table 33. Global Enoxaparin Sodium API Sales by Type (2023-2028) & (Tons)
Table 34. Global Enoxaparin Sodium API Sales Share by Type (2017-2022)
Table 35. Global Enoxaparin Sodium API Sales Share by Type (2023-2028)
Table 36. Global Enoxaparin Sodium API Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Enoxaparin Sodium API Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Enoxaparin Sodium API Revenue Share by Type (2017-2022)
Table 39. Global Enoxaparin Sodium API Revenue Share by Type (2023-2028)
Table 40. Enoxaparin Sodium API Price by Type (2017-2022) & (US$/Kg)
Table 41. Global Enoxaparin Sodium API Price Forecast by Type (2023-2028) & (US$/Kg)
Table 42. Global Enoxaparin Sodium API Sales by Application (2017-2022) & (Tons)
Table 43. Global Enoxaparin Sodium API Sales by Application (2023-2028) & (Tons)
Table 44. Global Enoxaparin Sodium API Sales Share by Application (2017-2022)
Table 45. Global Enoxaparin Sodium API Sales Share by Application (2023-2028)
Table 46. Global Enoxaparin Sodium API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Enoxaparin Sodium API Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Enoxaparin Sodium API Revenue Share by Application (2017-2022)
Table 49. Global Enoxaparin Sodium API Revenue Share by Application (2023-2028)
Table 50. Enoxaparin Sodium API Price by Application (2017-2022) & (US$/Kg)
Table 51. Global Enoxaparin Sodium API Price Forecast by Application (2023-2028) & (US$/Kg)
Table 52. North America Enoxaparin Sodium API Sales by Type (2017-2022) & (Tons)
Table 53. North America Enoxaparin Sodium API Sales by Type (2023-2028) & (Tons)
Table 54. North America Enoxaparin Sodium API Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Enoxaparin Sodium API Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Enoxaparin Sodium API Sales by Application (2017-2022) & (Tons)
Table 57. North America Enoxaparin Sodium API Sales by Application (2023-2028) & (Tons)
Table 58. North America Enoxaparin Sodium API Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Enoxaparin Sodium API Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Enoxaparin Sodium API Sales by Country (2017-2022) & (Tons)
Table 61. North America Enoxaparin Sodium API Sales by Country (2023-2028) & (Tons)
Table 62. North America Enoxaparin Sodium API Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Enoxaparin Sodium API Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Enoxaparin Sodium API Sales by Type (2017-2022) & (Tons)
Table 65. Europe Enoxaparin Sodium API Sales by Type (2023-2028) & (Tons)
Table 66. Europe Enoxaparin Sodium API Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Enoxaparin Sodium API Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Enoxaparin Sodium API Sales by Application (2017-2022) & (Tons)
Table 69. Europe Enoxaparin Sodium API Sales by Application (2023-2028) & (Tons)
Table 70. Europe Enoxaparin Sodium API Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Enoxaparin Sodium API Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Enoxaparin Sodium API Sales by Country (2017-2022) & (Tons)
Table 73. Europe Enoxaparin Sodium API Sales by Country (2023-2028) & (Tons)
Table 74. Europe Enoxaparin Sodium API Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Enoxaparin Sodium API Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Enoxaparin Sodium API Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Enoxaparin Sodium API Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Enoxaparin Sodium API Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Enoxaparin Sodium API Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Enoxaparin Sodium API Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Enoxaparin Sodium API Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Enoxaparin Sodium API Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Enoxaparin Sodium API Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Enoxaparin Sodium API Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Enoxaparin Sodium API Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Enoxaparin Sodium API Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Enoxaparin Sodium API Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Enoxaparin Sodium API Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Enoxaparin Sodium API Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Enoxaparin Sodium API Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Enoxaparin Sodium API Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Enoxaparin Sodium API Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Enoxaparin Sodium API Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Enoxaparin Sodium API Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Enoxaparin Sodium API Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Enoxaparin Sodium API Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Enoxaparin Sodium API Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Enoxaparin Sodium API Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Enoxaparin Sodium API Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Enoxaparin Sodium API Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Enoxaparin Sodium API Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Enoxaparin Sodium API Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Enoxaparin Sodium API Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Enoxaparin Sodium API Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Enoxaparin Sodium API Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Enoxaparin Sodium API Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Enoxaparin Sodium API Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Enoxaparin Sodium API Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Enoxaparin Sodium API Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Enoxaparin Sodium API Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Enoxaparin Sodium API Revenue by Country (2023-2028) & (US$ Million)
Table 112. Techdow Corporation Information
Table 113. Techdow Description and Major Businesses
Table 114. Techdow Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 115. Techdow Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Techdow Recent Development
Table 117. Qingdao Kangyuan Pharmaceutical Corporation Information
Table 118. Qingdao Kangyuan Pharmaceutical Description and Major Businesses
Table 119. Qingdao Kangyuan Pharmaceutical Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 120. Qingdao Kangyuan Pharmaceutical Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Qingdao Kangyuan Pharmaceutical Recent Development
Table 122. CSBIO Corporation Information
Table 123. CSBIO Description and Major Businesses
Table 124. CSBIO Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 125. CSBIO Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. CSBIO Recent Development
Table 127. Dongcheng Pharmaceutical Corporation Information
Table 128. Dongcheng Pharmaceutical Description and Major Businesses
Table 129. Dongcheng Pharmaceutical Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 130. Dongcheng Pharmaceutical Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Dongcheng Pharmaceutical Recent Development
Table 132. Hepalink Pharmaceutical Group Corporation Information
Table 133. Hepalink Pharmaceutical Group Description and Major Businesses
Table 134. Hepalink Pharmaceutical Group Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 135. Hepalink Pharmaceutical Group Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Hepalink Pharmaceutical Group Recent Development
Table 137. Cisen Pharmaceutical Corporation Information
Table 138. Cisen Pharmaceutical Description and Major Businesses
Table 139. Cisen Pharmaceutical Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 140. Cisen Pharmaceutical Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Cisen Pharmaceutical Recent Development
Table 142. Qianhong Biopharma Corporation Information
Table 143. Qianhong Biopharma Description and Major Businesses
Table 144. Qianhong Biopharma Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 145. Qianhong Biopharma Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Qianhong Biopharma Recent Development
Table 147. Nanjing King-friend Corporation Information
Table 148. Nanjing King-friend Description and Major Businesses
Table 149. Nanjing King-friend Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 150. Nanjing King-friend Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Nanjing King-friend Recent Development
Table 152. Haike Group Corporation Information
Table 153. Haike Group Description and Major Businesses
Table 154. Haike Group Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 155. Haike Group Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Haike Group Recent Development
Table 157. Yino Pharma Corporation Information
Table 158. Yino Pharma Description and Major Businesses
Table 159. Yino Pharma Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 160. Yino Pharma Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Yino Pharma Recent Development
Table 162. Tianjin Chasesun Pharmaceutical Corporation Information
Table 163. Tianjin Chasesun Pharmaceutical Description and Major Businesses
Table 164. Tianjin Chasesun Pharmaceutical Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 165. Tianjin Chasesun Pharmaceutical Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Tianjin Chasesun Pharmaceutical Recent Development
Table 167. Erye Pharmaceutical Corporation Information
Table 168. Erye Pharmaceutical Description and Major Businesses
Table 169. Erye Pharmaceutical Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 170. Erye Pharmaceutical Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Erye Pharmaceutical Recent Development
Table 172. Ronnsi Pharma Corporation Information
Table 173. Ronnsi Pharma Description and Major Businesses
Table 174. Ronnsi Pharma Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 175. Ronnsi Pharma Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Ronnsi Pharma Recent Development
Table 177. Amphastar Pharmaceuticals Corporation Information
Table 178. Amphastar Pharmaceuticals Description and Major Businesses
Table 179. Amphastar Pharmaceuticals Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 180. Amphastar Pharmaceuticals Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Amphastar Pharmaceuticals Recent Development
Table 182. Suanfarma Corporation Information
Table 183. Suanfarma Description and Major Businesses
Table 184. Suanfarma Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 185. Suanfarma Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Suanfarma Recent Development
Table 187. SAJJALA BIO LABS Corporation Information
Table 188. SAJJALA BIO LABS Description and Major Businesses
Table 189. SAJJALA BIO LABS Enoxaparin Sodium API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 190. SAJJALA BIO LABS Enoxaparin Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. SAJJALA BIO LABS Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Enoxaparin Sodium API Distributors List
Table 195. Enoxaparin Sodium API Customers List
Table 196. Enoxaparin Sodium API Market Trends
Table 197. Enoxaparin Sodium API Market Drivers
Table 198. Enoxaparin Sodium API Market Challenges
Table 199. Enoxaparin Sodium API Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Enoxaparin Sodium API Product Picture
Figure 2. Global Enoxaparin Sodium API Market Share by Type in 2021 & 2028
Figure 3. Purity ≥99% Product Picture
Figure 4. Purity ≥99.5% Product Picture
Figure 5. Global Enoxaparin Sodium API Market Share by Application in 2021 & 2028
Figure 6. Injection Solution
Figure 7. Reagent
Figure 8. Other
Figure 9. Enoxaparin Sodium API Report Years Considered
Figure 10. Global Enoxaparin Sodium API Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 11. Global Enoxaparin Sodium API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Enoxaparin Sodium API Production Market Share by Region (2017-2022)
Figure 13. Global Enoxaparin Sodium API Production Market Share by Region (2023-2028)
Figure 14. Enoxaparin Sodium API Production Growth Rate in North America (2017-2028) & (Tons)
Figure 15. Enoxaparin Sodium API Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 16. Enoxaparin Sodium API Production Growth Rate in China (2017-2028) & (Tons)
Figure 17. Global Enoxaparin Sodium API Sales 2017-2028 (Tons)
Figure 18. Global Enoxaparin Sodium API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Enoxaparin Sodium API Revenue 2017-2028 (US$ Million)
Figure 20. Global Enoxaparin Sodium API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Enoxaparin Sodium API Sales Market Share by Region (2017-2022)
Figure 22. Global Enoxaparin Sodium API Sales Market Share by Region (2023-2028)
Figure 23. North America Enoxaparin Sodium API Sales YoY (2017-2028) & (Tons)
Figure 24. North America Enoxaparin Sodium API Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Enoxaparin Sodium API Sales YoY (2017-2028) & (Tons)
Figure 26. Europe Enoxaparin Sodium API Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Enoxaparin Sodium API Sales YoY (2017-2028) & (Tons)
Figure 28. Asia-Pacific Enoxaparin Sodium API Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Enoxaparin Sodium API Sales YoY (2017-2028) & (Tons)
Figure 30. Latin America Enoxaparin Sodium API Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Enoxaparin Sodium API Sales YoY (2017-2028) & (Tons)
Figure 32. Middle East & Africa Enoxaparin Sodium API Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Enoxaparin Sodium API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Enoxaparin Sodium API in the World: Market Share by Enoxaparin Sodium API Revenue in 2021
Figure 35. Enoxaparin Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Enoxaparin Sodium API Sales Market Share by Type (2017-2028)
Figure 37. Global Enoxaparin Sodium API Revenue Market Share by Type (2017-2028)
Figure 38. Global Enoxaparin Sodium API Sales Market Share by Application (2017-2028)
Figure 39. Global Enoxaparin Sodium API Revenue Market Share by Application (2017-2028)
Figure 40. North America Enoxaparin Sodium API Sales Market Share by Type (2017-2028)
Figure 41. North America Enoxaparin Sodium API Revenue Market Share by Type (2017-2028)
Figure 42. North America Enoxaparin Sodium API Sales Market Share by Application (2017-2028)
Figure 43. North America Enoxaparin Sodium API Revenue Market Share by Application (2017-2028)
Figure 44. North America Enoxaparin Sodium API Sales Share by Country (2017-2028)
Figure 45. North America Enoxaparin Sodium API Revenue Share by Country (2017-2028)
Figure 46. United States Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Enoxaparin Sodium API Sales Market Share by Type (2017-2028)
Figure 49. Europe Enoxaparin Sodium API Revenue Market Share by Type (2017-2028)
Figure 50. Europe Enoxaparin Sodium API Sales Market Share by Application (2017-2028)
Figure 51. Europe Enoxaparin Sodium API Revenue Market Share by Application (2017-2028)
Figure 52. Europe Enoxaparin Sodium API Sales Share by Country (2017-2028)
Figure 53. Europe Enoxaparin Sodium API Revenue Share by Country (2017-2028)
Figure 54. Germany Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 55. France Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Enoxaparin Sodium API Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific Enoxaparin Sodium API Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific Enoxaparin Sodium API Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Enoxaparin Sodium API Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Enoxaparin Sodium API Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Enoxaparin Sodium API Revenue Share by Region (2017-2028)
Figure 65. China Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 68. India Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 70. China Taiwan Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Enoxaparin Sodium API Sales Market Share by Type (2017-2028)
Figure 75. Latin America Enoxaparin Sodium API Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Enoxaparin Sodium API Sales Market Share by Application (2017-2028)
Figure 77. Latin America Enoxaparin Sodium API Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Enoxaparin Sodium API Sales Share by Country (2017-2028)
Figure 79. Latin America Enoxaparin Sodium API Revenue Share by Country (2017-2028)
Figure 80. Mexico Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Enoxaparin Sodium API Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Enoxaparin Sodium API Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Enoxaparin Sodium API Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Enoxaparin Sodium API Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Enoxaparin Sodium API Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Enoxaparin Sodium API Revenue Share by Country (2017-2028)
Figure 89. Turkey Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Enoxaparin Sodium API Revenue (2017-2028) & (US$ Million)
Figure 92. Enoxaparin Sodium API Value Chain
Figure 93. Enoxaparin Sodium API Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

以下、関連資料のご紹介

ダルテパリンナトリウムAPIのグローバル市場インサイト・予測（～2028年）

Global Dalteparin Sodium API Market Insights, Forecast to 2028
QY2207C1034 2022年7月8日 112Pages
新型コロナウイルス感染症のパンデミックにより、世界のダルテパリンナトリウムAPIの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にダルテパ...

デキサメタゾンリン酸ナトリウムAPIのグローバル市場インサイト・予測（～2028年）

Global Dexamethasone Sodium Phosphate API Market Insights, Forecast to 2028
QY2207C1066 2022年7月8日 108Pages
新型コロナウイルス感染症のパンデミックにより、世界のデキサメタゾンリン酸ナトリウムAPIの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...

世界の医薬品用重曹ナトリウム市場予測（～2028年）：細粒、粗粒

Global Pharmaceutical Grade Sodium Bicarbonate Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E2077 2022年5月 111Pages
医薬品用重曹ナトリウム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供しま...

シチコリンナトリウムのグローバル市場インサイト・予測（～2028年）

Global Citicoline Sodium Market Insights, Forecast to 2028
QY2207C0849 2022年7月8日 94Pages
新型コロナウイルス感染症のパンデミックにより、世界のシチコリンナトリウムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にシチコリンナトリ...

世界の乳酸ナトリウム市場予測（～2028年）：食品用、医薬品用、その他

Global Sodium Lactylate Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E2474 2022年5月 101Pages
乳酸ナトリウム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。

ダルテパリンナトリウムAPIのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Dalteparin Sodium API Market Due to the COVID-19 pandemic, the global Dalteparin Sodium API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.…
シチコリンナトリウムのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Citicoline Sodium Market Due to the COVID-19 pandemic, the global Citicoline Sodium market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully c…
世界のヒドロキシメチルグリシン酸ナトリウム市場予測（～2028年）：95％（純度）、98％（純度）、99％（純度） The Sodium Hydroxymethylglycinate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
デキサメタゾンリン酸ナトリウムAPIのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Dexamethasone Sodium Phosphate API Market Due to the COVID-19 pandemic, the global Dexamethasone Sodium Phosphate API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the …
フシデートナトリウムのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Fusidate Sodium Market Due to the COVID-19 pandemic, the global Fusidate Sodium market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully consi…